Learn from the experts: Evolut first implant technique and treatment strategies

Sponsored by Medtronic

Discussants: T. Sakamoto, K. Zen, G. Attizzani, V. Kushwaha, S. Fukuhara

Anchorperson: M. Tabata

Summary

This expert-led session offers an in-depth review of evolving clinical practices in aortic valve disease treatment, emphasizing the potential of the transcarotid approach as a primary alternative access route. It compares current strategies including TAVI, surgical aortic valve replacement (SAV), TAV-in-SAV, and TAVI explantation, while addressing patient selection, anatomical factors, and risk-benefit analyses. Additionally, it presents optimal implant techniques such as pacing and deployment strategies to improve procedural safety and outcomes in modern TAVI.

Learning Objectives

To learn more about clinical practices evolution: could transcarotid approach be the first alternative?
To compare and contrast current treatment strategies for aortic valve disease, including TAVI, surgical aortic valve replacement (SAV), TAV-in-SAV, and TAVI explantation
To evaluate patient selection criteria, anatomical considerations, and risk–benefit profiles that inform decision-making across the lifetime management pathway
To discuss optimal implant practices, including pacing and deployment strategies, that enhance safety and outcomes in modern TAVI procedures